Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
PLoS One
    January 2025

  1. Correction: Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.
    PLoS One. 2025;20:e0317538.
    >> Share

  2. HASSAN S, Yaesoubi R, Magnus OBH, Kanthali M, et al
    Factors associated with the delay in diagnosis of extrapulmonary tuberculosis at the patient and health system level: A study from a rural setting in India.
    PLoS One. 2025;20:e0316273.
    >> Share

  3. WONDIE WT, Wubneh CA, Legesse BT, Mekonen GB, et al
    Mortality and predictors among HIV-TB co-infected patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317048.
    >> Share

  4. XU XY, Zhou ZY, Gong LQ, Xu LQ, et al
    Spatial epidemiological analysis based on township scale and analysis of influencing factors of pulmonary tuberculosis cure of Changshu city from 2015 to 2022.
    PLoS One. 2025;20:e0317269.
    >> Share

  5. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    The impact of tuberculosis-induced hyperglycemia on pulmonary microbiota and airway mucus secretion in individuals not previously diabetic: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0316810.
    >> Share

  6. TILAHUN M, Wegayehu T, Wondale B, Gebresilase TT, et al
    Correction: Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    PLoS One. 2025;20:e0318279.
    >> Share

  7. DRUSZCZYNSKA M, Seweryn M, Wawrocki S, Pankowska A, et al
    Interferon (IFN)-gamma (gamma) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population.
    PLoS One. 2025;20:e0314400.
    >> Share

  8. BHEEMIREDDY S, Sowdhamini R, Srinivasan N
    Computational analysis of the effect of a binding protein (RbpA) on the dynamics of Mycobacterium tuberculosis RNA polymerase assembly.
    PLoS One. 2025;20:e0317187.
    >> Share

  9. MULUGETA KT, Dawed MY, Teklu SW
    Impact of media coverage on the transmission dynamics of TB with vaccines and treatment.
    PLoS One. 2025;20:e0314324.
    >> Share

  10. JAMA SS, Abdi MM
    Tuberculosis treatment outcomes and associated factors among patients treated at Bosaso TB Hospital, Bosaso, Somalia: A five-year retrospective study.
    PLoS One. 2025;20:e0314693.
    >> Share

  11. MAHAWAN N, Rattananupong T, Sri-Uam P, Jiamjarasrangsi W, et al
    Performance of five dynamic models in predicting tuberculosis incidence in three prisons in Thailand.
    PLoS One. 2025;20:e0318089.
    >> Share

  12. PERWITASARI DA, Faridah IN, Dania H, Setiawan D, et al
    Machine learning model to predict the adherence of tuberculosis patients experiencing increased levels of liver enzymes in Indonesia.
    PLoS One. 2025;20:e0315912.
    >> Share

  13. KIMULI D, Nakaggwa F, Namuwenge N, Kamara V, et al
    Level of tuberculosis-related stigma and associated factors in Ugandan communities.
    PLoS One. 2025;20:e0313750.
    >> Share

  14. HAMISI MA, Asri NAM, Yassim ASM, Suppian R, et al
    A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials.
    PLoS One. 2025;20:e0317233.
    >> Share

  15. JOSHI L, Ponnana M, Sivangala R, Chelluri LK, et al
    Correction: Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.
    PLoS One. 2025;20:e0318949.
    >> Share

  16. GEBEYEHU EM, Mebratu A, Atnafu A, Hagos A, et al
    Process evaluation of Tuberculosis infection control and prevention practice at public health facilities in Tegede district, Northwest Ethiopia: Facility-based cross-sectional design.
    PLoS One. 2025;20:e0314514.
    >> Share

  17. BATISTA FAM, Araujo JIF, Soares FC, Schlosser TCM, et al
    Factors associated with pulmonary tuberculosis in elderly individuals: A protocol for a scoping review.
    PLoS One. 2025;20:e0318375.
    >> Share

  18. SIAME L, Chama GC, Masenga SK
    Correlates of tuberculosis in children under the age of 15 years.
    PLoS One. 2025;20:e0312570.
    >> Share

  19. MURPHY-OKPALA N, Eze C, Ossai EN, Agu CI, et al
    Enhancing programmatic scale-up: Applying the consolidated framework for implementation research to evaluate decentralized drug-resistant tuberculosis services in Southern Nigeria.
    PLoS One. 2025;20:e0318274.
    >> Share

  20. CANDELORO L, Savini L, Conte A, Calistri P, et al
    T-Racing: a modern tool for supporting epidemiological investigation in animal disease outbreaks in Italy.
    PLoS One. 2025;20:e0317313.
    >> Share

  21. SEID G, Alemu A, Diriba G, Hailu M, et al
    Active tuberculosis in household contacts of bacteriologically confirmed pulmonary tuberculosis patients: A multicenter study finding the 'Missed One' in Central Ethiopia.
    PLoS One. 2025;20:e0316903.
    >> Share

  22. TURYAHABWE S, Ramachandra SS, Quraishi S, Fasih I, et al
    A community based, bottom-up, multi-pronged, technology integrated approach to enhance tuberculosis related awareness and treatment adherence in Uganda: The ACTS model.
    PLoS One. 2025;20:e0318174.
    >> Share

  23. LING Y, Shen Y, Xu X, Yu G, et al
    Accuracy of next-generation sequencing for rapid diagnosis of tuberculous pleurisy: A protocol of systematic review and meta-analysis.
    PLoS One. 2025;20:e0319175.
    >> Share

  24. JINKS RC, Lesellier S, Smith F, Menzies FD, et al
    Evaluating sensitivity and specificity of the DPP Vet TB assay in badgers using Bayesian latent class models.
    PLoS One. 2025;20:e0313825.
    >> Share

  25. ARYA R, Shakya H, Chaurasia R, Kumar S, et al
    Correction: Computational reassessment of RNA-seq data reveals key genes in active tuberculosis.
    PLoS One. 2025;20:e0319694.
    >> Share

  26. COLLINS JM, Kipiani M, Jin Y, Sharma AA, et al
    Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.
    PLoS One. 2025;20:e0315999.
    >> Share

  27. CHITPIM N, Praditsitthikorn N, White LJ, Meeyai A, et al
    Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach.
    PLoS One. 2025;20:e0315772.
    >> Share

  28. LI X, Li Y, Guo L, Chen Y, et al
    Tuberculosis incidence, deaths and disability-adjusted life years in children and adolescence, 1990-2021: Results from the Global Burden of Disease Study 2021.
    PLoS One. 2025;20:e0317880.
    >> Share

  29. BIRU M, Datiko DG, Jerene D, Yohannes AG, et al
    Designing tuberculosis elimination framework through participatory processes in Ethiopia: Results from stakeholders' discussions.
    PLoS One. 2025;20:e0318209.
    >> Share

  30. ABOMA M, Abdisa B, Imana G, Taye K, et al
    Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia.
    PLoS One. 2025;20:e0319676.
    >> Share

  31. HUEDA-ZAVALETA M, de la Torre JCG, Barletta-Carrillo C, Tapia-Sequeiros G, et al
    Cytochemical analysis of cerebrospinal fluid in tuberculous meningitis versus other etiologies.
    PLoS One. 2025;20:e0318398.
    >> Share

  32. GRONNINGEN E, Nanyaro M, Ngadaya E, Mustafa T, et al
    Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania.
    PLoS One. 2025;20:e0320691.
    >> Share

  33. RIZZI A, Nucera E, Mazzucco W, Palumbo P, et al
    An interoperable web-based platform to support health surveillance against latent tuberculosis infection in health care workers and students: The evolution of CROSSWORD study protocol.
    PLoS One. 2025;20:e0319568.
    >> Share


  34. Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2025;20:e0321797.
    >> Share

  35. DODANI SK, Babar ZU, Mohammad KG, Ali S, et al
    Clinical presentation and outcome of tuberculosis in chronic kidney disease stage 4 & 5 from a high TB burden country.
    PLoS One. 2025;20:e0320907.
    >> Share

  36. LESTARI BW, Saptiningrum E, Huria L, Fikri AR, et al
    Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia.
    PLoS One. 2025;20:e0320401.
    >> Share

  37. WEI X, Liang D, Zhang Z, Thorpe KE, et al
    Active case finding using mobile vans with artificial intelligence aided radiology tests and sputum collection for rapid diagnostic tests to reduce tuberculosis prevalence among high-risk population in rural China: Protocol for a pragmatic trial.
    PLoS One. 2025;20:e0316073.
    >> Share

  38. MESERVE K, Chapman CA, Xu M, Zhou H, et al
    Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification.
    PLoS One. 2025;20:e0316648.
    >> Share

  39. TILAHUN M, Atnafu A, Gebresilase TT, Abebe M, et al
    Genotypic drug resistance and transmission clusters of Mycobacterium tuberculosis isolates among Ethiopian returnees from Saudi Arabia.
    PLoS One. 2025;20:e0318743.
    >> Share

  40. MUZEYI W, Babirekere E, Kalibbala D, Katamba A, et al
    Determinants and barriers in early tuberculosis treatment in children at a primary health care facility in Kampala, Uganda; A mixed methods study.
    PLoS One. 2025;20:e0321620.
    >> Share

  41. BALAKRISHNAN V, Kumaresan T, Surendra H, Allsop M, et al
    Developing and assessing MyTBCompanion - A tri-lingual integrated video observed therapy app for tuberculosis patient management in Malaysia and Indonesia.
    PLoS One. 2025;20:e0320394.
    >> Share

  42. KIM KY, Park YM, Ko SH, Han K, et al
    Baseline lung function and risk of incident tuberculosis: a nationwide population-based cohort study.
    PLoS One. 2025;20:e0322616.
    >> Share

  43. AGIZEW TB, Soka J, Mwimanzi S, Fast CD, et al
    The incremental value of tuberculosis detecting African giant pouched rats over Smear microscopy and Xpert MTB/RIF for Tanzanian TB detection.
    PLoS One. 2025;20:e0321866.
    >> Share

  44. ASARE-BAAH M, Johnston L, Dominique L, Lauzardo M, et al
    Timing and predictors of disease incidence among named contacts of reported tuberculosis patients in a low incidence setting.
    PLoS One. 2025;20:e0313801.
    >> Share

  45. CHEN ZK, Wu Z, Ye T, Lin CY, et al
    Exploring the accuracy of the Xpert MTB/RIF assay in detecting lymph node tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321507.
    >> Share

  46. JIANG D, Qin L, Pan W, Yan S, et al
    The value of high-pitch scanning with Sn100kV and ADMIRE in CT examination of tuberculous destroyed lung: Identifying the optimal combination for ultra-low-dose imaging.
    PLoS One. 2025;20:e0322374.
    >> Share

  47. PUNGARTNIK PC, Viana PVS, Santos JPCD, Macedo LR, et al
    Spatial analysis of drug resistant tuberculosis (DRTB) incidence and relationships with determinants in Rio de Janeiro state, 2010 to 2022.
    PLoS One. 2025;20:e0321553.
    >> Share

  48. SHIN E, Yun JS, Lee YR, Cha HR, et al
    Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
    PLoS One. 2025;20:e0322147.
    >> Share

  49. BEYENE RA, Janse van Rensburg E
    Prevention and control of multidrug-resistance tuberculosis in Ethiopia: Patients' perspectives from the Oromia region.
    PLoS One. 2025;20:e0322054.
    >> Share

  50. NTSHIQA T, Velen K, Ginindza S, Nhlangulela L, et al
    Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa.
    PLoS One. 2025;20:e0318819.
    >> Share

  51. YIRENKYI SO, Taufik O, Laryea R, Acquah-Keelson A, et al
    Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB.
    PLoS One. 2025;20:e0323527.
    >> Share

  52. ZHOU Y, Anthony R, Wang S, Xia H, et al
    Understanding the epidemiology and pathogenesis of Mycobacterium tuberculosis with non-redundant pangenome of epidemic strains in China.
    PLoS One. 2025;20:e0324152.
    >> Share

  53. MCINZIBA A, Wademan DT, Zimri K, Jacobs S, et al
    Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South Africa.
    PLoS One. 2025;20:e0323492.
    >> Share

  54. MINJA LT, Minja LM, Mlalama K, Pamba D, et al
    Facilitators, barriers, and strategies for the implementation of peer-led tuberculosis active case finding among people who use drugs in Dar es Salaam, Tanzania.
    PLoS One. 2025;20:e0310069.
    >> Share

  55. AHMED FM, Girma M, Worku G, Tadesse T, et al
    Bovine tuberculosis in cattle slaughtered at Addis Ababa abattoir in Ethiopia and workforce awareness of zoonotic risk.
    PLoS One. 2025;20:e0321844.
    >> Share

  56. YANG C, Gao W, Guo Y, Zeng Y, et al
    Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens.
    PLoS One. 2025;20:e0324003.
    >> Share

  57. DONG THK, Canas LS, Donovan J, Beasley D, et al
    Convolutional neural network using magnetic resonance brain imaging to predict outcome from tuberculosis meningitis.
    PLoS One. 2025;20:e0321655.
    >> Share

  58. SHARMA N, Sharma N, Biswas A, Gupta S, et al
    Iron-restricted Mycobacterium tuberculosis exports pathogenicity factors packed in extracellular vesicles.
    PLoS One. 2025;20:e0324919.
    >> Share

  59. VANQA N, Viljoen L, Hoddinott G, Hesseling A, et al
    Lessons from a systematic tracing process aimed to reduce initial loss to follow-up (ILTFU) among people diagnosed with tuberculosis (TB) in Cape Town, South Africa.
    PLoS One. 2025;20:e0323943.
    >> Share

  60. MBUH TP, Amveilla AP, Mendjime P, Donkeng Donfack VF, et al
    Evaluating turnaround time to improve clients' satisfaction in the tuberculosis reference laboratory in Douala.
    PLoS One. 2025;20:e0323917.
    >> Share

  61. YAO L, Bu C, Xiang L
    The diagnostic accuracy of nanopore sequencing in Tuberculous Lymphadenitis: Systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0325370.
    >> Share

  62. SAINI P, Bhattacharyya S
    Impact of multiple consultations and switching in treatment-seeking in tuberculosis: Mathematical modelling and optimal control.
    PLoS One. 2025;20:e0324330.
    >> Share

  63. DE ZWAAN R, de Vries G, Ubbelohde E, Mulder A, et al
    Verification of emerging genomic mutations in Mycobacterium tuberculosis allows transmission chains to be distinguished in an epidemiological typing cluster extending over thirty years.
    PLoS One. 2025;20:e0319630.
    >> Share

  64. ZHOU Y, Lv X, Zhu S, Xu P, et al
    The characteristics of latent tuberculosis infection and its influencing factors in hospitalized patients in Suzhou, Jiangsu, China.
    PLoS One. 2025;20:e0322913.
    >> Share

  65. GAGNON S, Ametepe E, Point F, Cloutier Charette W, et al
    TBpore cluster: A novel phylogenetic pipeline for tuberculosis transmission studies using nanopore next-generation sequencing data.
    PLoS One. 2025;20:e0325914.
    >> Share

  66. STEIN R, Fastenau A, Aman H, Ortuno-Gutierrez N, et al
    Understanding stigma: The experiences of people with drug-sensitive pulmonary tuberculosis in Rawalpindi, Pakistan.
    PLoS One. 2025;20:e0324614.
    >> Share

  67. CORDEIRO DC, Kuabara P, Amaral BC, Portugal LM, et al
    Needs assessment and preparedness of the primary health care network for scaling-up preventive tuberculosis treatment in 5 Brazilian capitals.
    PLoS One. 2025;20:e0326428.
    >> Share

  68. SILVA RDD, Farias ERG, Graca JMBD, Pinheiro EMN, et al
    Approaches and results of intersectoral actions for tuberculosis control in the world: A scoping review.
    PLoS One. 2025;20:e0326784.
    >> Share

  69. BELHEOUANE M, Kalsdorf B, Niemann S, Gaede KI, et al
    Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases.
    PLoS One. 2025;20:e0325362.
    >> Share

  70. TAREKEGN TB, Alemkere G, Ali EE
    Health-Related Quality of Life measured with EQ-5D-5L among tuberculosis patients in Addis Ababa, Ethiopia: Institutional-based cross-sectional study.
    PLoS One. 2025;20:e0326033.
    >> Share

  71. KELLER S, Naidoo K, Zekarias M, Israel-Isah S, et al
    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.
    PLoS One. 2025;20:e0326342.
    >> Share

  72. INTHAVONG D, Elsayed H, Keonakhone P, Seevisay V, et al
    The prevalence of undernutrition and associated risk factors in people with tuberculosis in Lao People's Democratic Republic.
    PLoS One. 2025;20:e0324838.
    >> Share

  73. S A, S S, K N, M M, et al
    Breaking barriers for TB elimination: A novel community-led strategy revolutionizing tuberculosis case finding and treatment support in Senapati District Manipur-A quasi-experimental pre-post study protocol.
    PLoS One. 2025;20:e0326324.
    >> Share

  74. JENNINGS K, Lembani M, Hesseling AC, Mbula N, et al
    Correction: A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.
    PLoS One. 2025;20:e0327683.
    >> Share

  75. ZHANG F, Gao Y, Li T, Zhang W, et al
    Development and validation of a nomogram for predicting false negative IGRA results in pulmonary tuberculosis patients using propensity score matching.
    PLoS One. 2025;20:e0327767.
    >> Share

  76. NGMENBELLE D, Amoa-Saah B, Nimirkpen S, Akesem MA, et al
    Spatiotemporal hotspot analysis of tuberculosis lost to follow-up cases in Ghana: A district-level study from 2019-2023.
    PLoS One. 2025;20:e0326444.
    >> Share

  77. AHMED S, Biswas S, Rahman T, Adel ASS, et al
    Mixed-methods study to assess delay among patients with tuberculosis in an urban setting of Bangladesh.
    PLoS One. 2025;20:e0327348.
    >> Share

  78. FENWICK MK, DeRocher AE, Craig JK, Harmon EK, et al
    Crystal structures of Mycobacterium tuberculosis and Mycobacterium thermoresistibile glycyl-tRNA synthetases in various liganded states.
    PLoS One. 2025;20:e0326500.
    >> Share

  79. LI N, Wei W, Lao Y, Zhu X, et al
    Long-term trends and future projections of the burden of tuberculosis among children and adolescents in China.
    PLoS One. 2025;20:e0328255.
    >> Share

  80. TEIBO TKA, Berra TZ, Alves YM, Tavares RBV, et al
    Surveillance of tuberculosis incidence and mortality through spatio-temporal analysis in Oyo State, Nigeria.
    PLoS One. 2025;20:e0311739.
    >> Share

  81. MAGHRADZE N, Loiseau C, Goig GA, Bablishvili N, et al
    Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia.
    PLoS One. 2025;20:e0326794.
    >> Share

  82. ROBERTI J, Carmiol-Rodriguez P, Chan-Liang E, Aguilar-Vidrio OA, et al
    Enhancing tuberculosis treatment support: A thematic analysis of interactive messages in a digital adherence technology trial to identify needs, challenges, and strategies for improvement.
    PLoS One. 2025;20:e0326492.
    >> Share

  83. MAHALINGAM V, Malaisamy M, Daniel BD, Bhaskar A, et al
    Health related quality of life of tuberculosis patients in South India: A longitudinal assessment study.
    PLoS One. 2025;20:e0328484.
    >> Share

  84. GUPTA AJ, Turimumahoro P, Rosman L, Golub JE, et al
    Methodologies for studying depression in persons living with tuberculosis: Protocol for a scoping review.
    PLoS One. 2025;20:e0322753.
    >> Share

  85. SMITH GC, Budgey R
    Bovine tuberculosis model validation against a field study of badger vaccination with selective culling.
    PLoS One. 2025;20:e0320830.
    >> Share

  86. SHEWADE HD, Ravichandran P, Satish S, Pradeep SK, et al
    Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024).
    PLoS One. 2025;20:e0328619.
    >> Share

  87. MERT A, Derin O, Zerdali E, Kaya A, et al
    Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Turkiye (2014-2024) ClinSurv HIV cohort: A large case series.
    PLoS One. 2025;20:e0329267.
    >> Share

  88. KUNJOK DM, Mwangi JG, Kairu-Wanyoike S, Kinyua J, et al
    Spatial epidemiology of tuberculosis diagnostic delays, healthcare access disparities, and socioeconomic inequities in Nairobi County, Kenya.
    PLoS One. 2025;20:e0329984.
    >> Share

  89. GALLEGATI M, Lopreite M, Puliga M
    Modeling the formation of a worldwide health network fighting TBC: Key drivers in policy, management and governance in developing countries and global health institutions.
    PLoS One. 2025;20:e0330538.
    >> Share

  90. MAENETJE N, Oladimeji M, Mlotshwa M, Hoft D, et al
    Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis.
    PLoS One. 2025;20:e0329562.
    >> Share

  91. SILVA JUNIOR JNB, Leal GDC, Ferreira QR, Andrade LKA, et al
    Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0330208.
    >> Share

  92. GARCIA-ZAMALLOA A, Arnay R, Castilla-Rodriguez I, Mar J, et al
    Machine learning for predicting the diagnosis of tuberculous versus malignant pleural effusion: External validation and accuracy in two different settings.
    PLoS One. 2025;20:e0329668.
    >> Share

  93. JARLSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Correction: Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2025;20:e0331721.
    >> Share

  94. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0327243.
    >> Share

  95. WEBER SF, Wolf R, Manten K, Thangakunam B, et al
    Lung and abdominal ultrasound accuracy for tuberculosis: An Indian prospective cohort study.
    PLoS One. 2025;20:e0329670.
    >> Share

  96. YISMAW L, Zewotir T, Muluneh EK, Getnet F, et al
    Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.
    PLoS One. 2025;20:e0331035.
    >> Share

  97. ZHANG R, Bao X, Bao F, Teng C, et al
    Evaluation of the Xpert MTB/XDR test for detection of isoniazid, fluoroquinolones, and second-line injectable drugs resistance to Mycobacterium tuberculosis-Anhui Province, China.
    PLoS One. 2025;20:e0331264.
    >> Share

  98. BA-IREDIRE E, Avoka JA, Abanga L, Darkie AA, et al
    Prevalence and factors influencing drug-resistant tuberculosis in four regions of Ghana.
    PLoS One. 2025;20:e0331958.
    >> Share

  99. YU Q, Yao R, Lei L, Shao X, et al
    A correlation analysis between nutritional status and physical function in the elderly with pulmonary tuberculosis.
    PLoS One. 2025;20:e0331700.
    >> Share

  100. RUEDAS-LOPEZ A, Herrero-Martinez JM, Reyes A, Gonzalez-Blanco B, et al
    Refining the diagnostic approach to latent tuberculosis Infection with Quantiferon gold plus: A retrospective analysis of borderline results.
    PLoS One. 2025;20:e0330345.
    >> Share

  101. HAYES MI, Ravishankar S, Qayum T, Nizet V, et al
    Transient vascular occlusions in a zebrafish model of mycobacterial brain infection.
    PLoS One. 2025;20:e0332161.
    >> Share

  102. DUBE TN, Mboniswa F, Qwana SE, Charalambous S, et al
    "If we lose it, we are worried": Individual and provider level perceptions towards weight change among people living with HIV who undergo TB screening in routine health care settings in Gauteng Province, South Africa.
    PLoS One. 2025;20:e0331904.
    >> Share

  103. NTSHIQA T, Fasanmi A, Nagudi J, Tsope L, et al
    Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings.
    PLoS One. 2025;20:e0332125.
    >> Share

  104. NAZNEEN A, Rahman T, Hossain A, Saha AK, et al
    Active case finding for tuberculosis in tea gardens of Bangladesh: A cross-sectional survey.
    PLoS One. 2025;20:e0333662.
    >> Share

  105. POUDEL S, Wagle L, Aryal TP, Adhikari B, et al
    Association between cardiometabolic risk factors and multidrug-resistant tuberculosis: A case-control study.
    PLoS One. 2025;20:e0333362.
    >> Share

  106. DUBE TN, Mboniswa F, de Groot L, Khumalo S, et al
    Acceptability of Digital Adherence Technologies to support people with drug-susceptible TB in South Africa.
    PLoS One. 2025;20:e0332103.
    >> Share

  107. MAHALINGAM V, Singh R, Santhanakrishnan RK, Bhaskar A, et al
    Generalized estimating equations for modeling cluster randomized trial data on smoking cessation among tuberculosis patients.
    PLoS One. 2025;20:e0333992.
    >> Share

  108. MLAMBO LM, Setlaleleng M, Shearer K, Mofokeng NJ, et al
    TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa.
    PLoS One. 2025;20:e0333367.
    >> Share

  109. SIDDIQUI MK, Khan S, Bhutia R, Nair V, et al
    Prevalence and factors associated with tuberculosis infection (TBI) among residents of a monastery situated in a high-TB burden area: A cross-sectional study, Sikkim, India.
    PLoS One. 2025;20:e0333583.
    >> Share

  110. AEMIRO A, Girma A, Alamnie G, Beletew D, et al
    Prevalence of opportunistic bacterial infections (tuberculosis and pneumonia) among people with HIV in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0315599.
    >> Share

  111. DAVID A, Peloakgosi-Shikwambani K, Nsingwane Z, Molepo V, et al
    Challenges, innovations and considerations for the use of tongue swabs in Mycobacterium tuberculosis complex detection.
    PLoS One. 2025;20:e0325585.
    >> Share

  112. YANG S, Ren Y, Wu Y, Li X, et al
    The impact of CwlM depletion on the susceptibility of Mycobacterium smegmatis to anti-tuberculosis drugs.
    PLoS One. 2025;20:e0334937.
    >> Share

  113. KIM A, Kim HW, Kim JS, Kim JW, et al
    Depressive episode and treatment outcomes in elderly individuals with tuberculosis: A prospective cohort study in Korea.
    PLoS One. 2025;20:e0335897.
    >> Share

  114. JIANG S, Wang H, Hu Y
    Analysis of drug-resistant tuberculosis transmission dynamics in China using fractional stochastic model.
    PLoS One. 2025;20:e0335889.
    >> Share

  115. TAYLOR AE, McDonald E, Henderson H, MacPherson P, et al
    The impact of latent tuberculosis screening programmes for migrant populations in high income, low burden countries.
    PLoS One. 2025;20:e0335904.
    >> Share

  116. BARAL T, Maile A, Adimurthy NH, Saravu K, et al
    Exploring gut microbiota and its predicted functions in pulmonary tuberculosis: A multi-regional study using public 16S datasets.
    PLoS One. 2025;20:e0336337.
    >> Share

  117. MOON D, Jeong D, Kang YA, Lee GI, et al
    Impact of active tuberculosis on social mobility and its gender differences: Difference in differences using nationwide tuberculosis surveillance data and national health insurance data.
    PLoS One. 2025;20:e0334961.
    >> Share

  118. KILIMA S, Hirasen K, Mubyazi G, Moolla A, et al
    Implications of pre-diagnosis costs incurred by patients and their families for tuberculosis-related health-seeking behaviors in Mbeya and Songwe regions, Tanzania.
    PLoS One. 2025;20:e0336270.
    >> Share


  119. Correction: Mixed-methods study to assess delay among patients with tuberculosis in an urban setting of Bangladesh.
    PLoS One. 2025;20:e0337339.
    >> Share

  120. KAAPU KG, Rukasha I
    Trends and treatment outcomes of drug resistant tuberculosis in Limpopo Province, South Africa (2011-2019): A Retrospective Study.
    PLoS One. 2025;20:e0335600.
    >> Share

  121. FENTA A, Dilnessa T, Kebede D, Belayneh M, et al
    Incidence and predictors of mortality among TB-HIV co-infected individuals on anti-tuberculosis and anti-retroviral dual therapy in Northwest Ethiopia: A retrospective cohort study.
    PLoS One. 2025;20:e0337612.
    >> Share

  122. MAENETJE N, Oladimeji M, Mlotshwa M, Price MA, et al
    Correction: Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis.
    PLoS One. 2025;20:e0337706.
    >> Share

  123. MARGINEANU I, Gafar F, Butnaru T, Baiceanu D, et al
    Factors influencing drug-susceptible tuberculosis treatment outcomes in Romania and Ukraine.
    PLoS One. 2025;20:e0337937.
    >> Share

  124. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Correction: Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0338017.
    >> Share

  125. NGWIRA A, Manda SOM, Karimuribo ED, Kimera SI, et al
    JSTMapp: A web-based joint spatiotemporal modelling and mapping application for epidemiologists.
    PLoS One. 2025;20:e0332607.
    >> Share

  126. OCTOBER CD, Baloyi DP, Viljoen L, Raad R, et al
    Using participatory methods to develop a narrative intervention to alleviate distress in children hospitalised with TB in South Africa: The DIMPle project.
    PLoS One. 2025;20:e0338394.
    >> Share

  127. ASMAMAW B, Tadese TT, Mamo RY, Taye BA, et al
    Magnitude of tuberculosis treatment outcomes and associated factors in public health institutions of Arba Minch town, Southern Ethiopia: A multi-centered retrospective cross-sectional study.
    PLoS One. 2025;20:e0338393.
    >> Share

  128. GETAHUN M, Kebede Y, Molalegn H, Alemu A, et al
    Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 - 14 years, at selected health facilities in Ethiopia, 2016 - 2019.
    PLoS One. 2025;20:e0338557.
    >> Share

  129. KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
    Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
    PLoS One. 2025;20:e0328957.
    >> Share

  130. DANSO EK, Asare P, Tetteh AY, Tetteh P, et al
    Mycobacterium tuberculosis complex lineages and drug resistance patterns among tuberculosis patients with or without diabetes mellitus in southern Ghana.
    PLoS One. 2025;20:e0338498.
    >> Share

    January 2024
  131. VOLKMAN T, Muruganandah V, Graham H, Tosif S, et al
    QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295913.
    >> Share

  132. MUGENYI L, Namuwenge PM, Ouma S, Bakashaba B, et al
    Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.
    PLoS One. 2024;19:e0296239.
    >> Share

  133. PEDRAZ T, Herrera L, Vazquez MC, Ramirez-Rubio O, et al
    The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012-2020.
    PLoS One. 2024;19:e0295918.
    >> Share

  134. HAI BB, Anh TL, Thi Thu PN, Van HN, et al
    Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
    PLoS One. 2024;19:e0295048.
    >> Share

  135. SPEKKER O, Kiss P A, Kis L, Kiraly K, et al
    White plague among the "forgotten people" from the Barbaricum of the Carpathian Basin-Cases with tuberculosis from the Sarmatian-period (3rd-4th centuries CE) archaeological site of Hodmezovasarhely-Kenyere-er, Bereczki-tanya (Hungary).
    PLoS One. 2024;19:e0294762.
    >> Share

  136. GUPTA A, Juneja S, Babawale V, Rustam Majidovich N, et al
    Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.
    PLoS One. 2024;19:e0296448.
    >> Share

  137. TESFAHUN HM, Al-Salihi L, Abdulkareem Al-Ani N, Mankhi AA, et al
    Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.
    PLoS One. 2024;19:e0296952.
    >> Share

  138. GIVE C, Morris C, Murray J, Jose B, et al
    Sociocultural understanding of Tuberculosis and implications for care-seeking among adults in the province of Zambezia, Mozambique: Qualitative research.
    PLoS One. 2024;19:e0289928.
    >> Share

  139. SANCHEZ-PEREZ HJ, Gordillo-Marroquin C, Vazquez-Marcelin J, Martin-Mateo M, et al
    Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022.
    PLoS One. 2024;19:e0296924.
    >> Share

  140. YAMANAKA T, Castro MC, Ferrer JP, Solon JA, et al
    Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.
    PLoS One. 2024;19:e0297342.
    >> Share

  141. SSEMASAAZI JA, Bongomin F, Akunzirwe R, Bayowa JR, et al
    Private practitioners' practices for tuberculosis management in a city largely served by the private health sector in Uganda.
    PLoS One. 2024;19:e0296422.
    >> Share

  142. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297828.
    >> Share

  143. LAXMESHWAR C, Das M, Mathur T, Israni T, et al
    Correction: Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
    PLoS One. 2024;19:e0298137.
    >> Share

  144. DAWOOD H, Yende-Zuma N, Singh U, Moodley MC, et al
    Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis.
    PLoS One. 2024;19:e0297224.
    >> Share

  145. WU Z, Li H, Wu J, Lai X, et al
    The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297477.
    >> Share

  146. GERBER F, Semphere R, Lukau B, Mahlatsi P, et al
    Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi.
    PLoS One. 2024;19:e0288944.
    >> Share

  147. SIMIENEH A, Gashaneh S, Dereje R
    Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.
    PLoS One. 2024;19:e0298244.
    >> Share

  148. AJEMA AT, Simachew Y, Meshesha MD, Gari T, et al
    Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
    PLoS One. 2024;19:e0298021.
    >> Share

  149. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2024;19:e0299477.
    >> Share

  150. POWELL SM, Jarsberg LG, Zionce ELM, Anderson LN, et al
    Longitudinal analysis of host protein serum signatures of treatment and recovery in pulmonary tuberculosis.
    PLoS One. 2024;19:e0294603.
    >> Share

  151. MESIC A, Khan WH, Lenglet A, Lynen L, et al
    Correction: Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
    PLoS One. 2024;19:e0299913.
    >> Share

  152. SERENE LG, Webber K, Champion PA, Schorey JS, et al
    Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I/MAVs signaling is not conserved in Mycobacterium marinum.
    PLoS One. 2024;19:e0281564.
    >> Share

  153. OSMAN M, Meehan SA, von Delft A, Preez KD, et al
    Correction: Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2024;19:e0300768.
    >> Share

  154. CUNHA R, Filho DBM, M Albuquerque MFP, Lacerda HR, et al
    The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    PLoS One. 2024;19:e0299244.
    >> Share

  155. KAUMBA PC, Siameka D, Kagujje M, Chungu C, et al
    Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.
    PLoS One. 2024;19:e0287876.
    >> Share

  156. APRIANI L, McAllister S, Sharples K, Aini IN, et al
    Tuberculin skin test and Interferon-gamma release assay agreement, and associated factors with latent tuberculosis infection, in medical and nursing students in Bandung, Indonesia.
    PLoS One. 2024;19:e0299874.
    >> Share

  157. JOBARTEH T, Otu J, Gitteh E, Mendy FS, et al
    The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia.
    PLoS One. 2024;19:e0300042.
    >> Share

  158. PADHI A, Agarwal A, Bhise M, Chaudhary A, et al
    Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0301060.
    >> Share

  159. MUNSHI T, Gupta A, Evangelopoulos D, Guzman JD, et al
    Correction: Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0301375.
    >> Share

  160. PETRUCCIANI A, Hoerter A, Kotze L, Du Plessis N, et al
    In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models.
    PLoS One. 2024;19:e0299107.
    >> Share

  161. PERESU E, De Graeve D, Heunis JC, Kigozi NG, et al
    Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
    PLoS One. 2024;19:e0301507.
    >> Share

  162. CAI N, Luo W, Ding L, Chen L, et al
    Obesity-related indicators and tuberculosis: A Mendelian randomization study.
    PLoS One. 2024;19:e0297905.
    >> Share

  163. OMONGOT S, Muttamba W, Najjingo I, Baruch Baluku J, et al
    Strategies to resolve the gap in adolescent tuberculosis care at four health facilities in Uganda: The teenager's TB pilot project.
    PLoS One. 2024;19:e0286894.
    >> Share

  164. CRUZ MARTINEZ OA, Garcia I, Puerto GM, Alvis-Zakzuk NJ, et al
    Tuberculosis patients face high treatment support costs in Colombia, 2021.
    PLoS One. 2024;19:e0296250.
    >> Share

  165. OTIENO J, Luciani A, Lumumba S, Gikunda G, et al
    Mental health issues associated with the management of tuberculosis in Homabay, Busia and Kakamega Counties, Kenya.
    PLoS One. 2024;19:e0298268.
    >> Share

  166. PAULOWSKI L, Filip R, Jankovic Makek M, Guglielmetti L, et al
    Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.
    PLoS One. 2024;19:e0291404.
    >> Share

  167. HIRSCH-MOVERMAN Y, Hsu A, Abrams EJ, Killam WP, et al
    Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.
    PLoS One. 2024;19:e0296993.
    >> Share

  168. GONZALEZ-REYES R, Katz D, Lambert L, Sorri Y, et al
    Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.
    PLoS One. 2024;19:e0298628.
    >> Share

  169. O'BRIEN A, Hayton A, Cutler K, Adler A, et al
    Diagnostic accuracy of the Enferplex Bovine TB antibody test using individual milk samples from cattle.
    PLoS One. 2024;19:e0301609.
    >> Share

  170. LIU CW, Wu LS, Lin CJ, Wu HC, et al
    Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3.
    PLoS One. 2024;19:e0303431.
    >> Share

  171. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    >> Share

  172. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    >> Share


  173. Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.
    >> Share

  174. CHAND AB, Basnet A, Maharjan B, Rai G, et al
    Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    PLoS One. 2024;19:e0301210.
    >> Share

  175. ARCONADA ALVAREZ SJ, Hoover AT, Greenleaf M, Ray SM, et al
    "An app is just available at all times"-the process and outcomes of converting the Georgia Tuberculosis Reference Guide into a mobile application.
    PLoS One. 2024;19:e0298758.
    >> Share

  176. YENEW B, Kebede A, Alemu A, Diriba G, et al
    Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
    PLoS One. 2024;19:e0303460.
    >> Share

  177. MOMANYI RK, Kwobah EK, Owiti P, Nyamogoba H, et al
    Psychiatric morbidity among patients on treatment for tuberculosis at a tertiary referral hospital in Western Kenya.
    PLoS One. 2024;19:e0302744.
    >> Share

  178. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    >> Share

  179. OPITO R, Kwenya K, Ssentongo SM, Kizito M, et al
    Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
    PLoS One. 2024;19:e0300916.
    >> Share

  180. RICKMAN HM, Phiri MD, Feasey HRA, Mbale H, et al
    Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.
    PLoS One. 2024;19:e0291215.
    >> Share

  181. HAYRE K, Takele MK, Birri DJ
    Tuberculosis treatment outcomes and associated factors at Alemgena Health Center, Sebeta, Oromia, Ethiopia.
    PLoS One. 2024;19:e0303797.
    >> Share

  182. SZEKELY R, Sossen B, Mukoka M, Muyoyeta M, et al
    Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability.
    PLoS One. 2024;19:e0303846.
    >> Share

  183. ABEBE M, Atnafu A, Tilahun M, Sero N, et al
    Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2024;19:e0304507.
    >> Share

  184. SONG Y, Zhao B, Wang S, Zheng Y, et al
    Proficiency of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China, 2008-2021.
    PLoS One. 2024;19:e0304265.
    >> Share

  185. AMUGE PM, Becker GL, Ssebunya RN, Nalumansi E, et al
    Patient characteristics and predictors of mortality among children hospitalised with tuberculosis: A six-year case series study in Uganda.
    PLoS One. 2024;19:e0301107.
    >> Share

  186. YU G, Xu X, Shen Y, Fang B, et al
    Diagnostic accuracy of nanopore sequencing for the rapid diagnosis of pulmonary tuberculosis: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0304162.
    >> Share

  187. DIPPENAAR A, Costa Conceicao E, Wells F, Loubser J, et al
    Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry.
    PLoS One. 2024;19:e0303938.
    >> Share

  188. PUYEN ZM, Santos-Lazaro D, Vigo AN, Cotrina VV, et al
    Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
    PLoS One. 2024;19:e0304130.
    >> Share

  189. DEKU JG, Aninagyei E, Bedzina I, Nudo G, et al
    Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana.
    PLoS One. 2024;19:e0305161.
    >> Share

  190. KETER AK, Vanobberghen F, Lynen L, Van Heerden A, et al
    Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis.
    PLoS One. 2024;19:e0305126.
    >> Share

  191. AHIMBISIBWE I, Tumusiime C, Muteebwa L, Mupere E, et al
    Prevalence of pulmonary tuberculosis among casual labourers working in selected road construction sites in central Uganda.
    PLoS One. 2024;19:e0304719.
    >> Share

  192. FARIA MGBF, Andrade RLP, Leite KFS, Bonfim RO, et al
    Operational indicators for pulmonary tuberculosis diagnosis in people living with HIV before and after Xpert MTB/RIF implementation in the state of Sao Paulo, Brazil.
    PLoS One. 2024;19:e0305063.
    >> Share

  193. GUTKA HJ, Bondoc JMG, Patwell R, Khan S, et al
    Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy.
    PLoS One. 2024;19:e0304876.
    >> Share

  194. ARYA R, Shakya H, Chaurasia R, Kumar S, et al
    Computational reassessment of RNA-seq data reveals key genes in active tuberculosis.
    PLoS One. 2024;19:e0305582.
    >> Share

  195. PEREZ-MARTINEZ DE, Zenteno-Cuevas R
    SNPs in genes related to the repair of damage to DNA in clinical isolates of M. tuberculosis: A transversal and longitudinal approach.
    PLoS One. 2024;19:e0295464.
    >> Share

  196. XIAN X, Li L, Ye J, Mo W, et al
    Betaine and I-LG may have a predictive value for ATB: A causal study in a large European population.
    PLoS One. 2024;19:e0306752.
    >> Share

  197. KASSAW A, Asferie WN, Azmeraw M, Kefale D, et al
    Incidence and predictors of tuberculosis among HIV-infected children after initiation of antiretroviral therapy in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0306651.
    >> Share

  198. PALACIOS CF, Chowdhary V, Hao R, Danve A, et al
    Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
    PLoS One. 2024;19:e0306337.
    >> Share

  199. MAHAWAN N, Rattananupong T, Sri-Uam P, Jiamjarasrangsi W, et al
    Assessment of tuberculosis transmission probability in three Thai prisons based on five dynamic models.
    PLoS One. 2024;19:e0305264.
    >> Share

  200. DLANGALALA T, Musekiwa A, Mashamba-Thompson T
    Quality of TB diagnostic services at primary healthcare clinics in eThekwini district, South Africa.
    PLoS One. 2024;19:e0307149.
    >> Share

  201. SHEN Y, Ling Y, Yu G, Zhang X, et al
    The value of nanopore sequencing as a diagnostic tool in tuberculous meningitis: A protocol of systematic review and meta-analysis.
    PLoS One. 2024;19:e0307389.
    >> Share

  202. ZAKARIA WMZ, Mansor Z
    Intention to receive Latent Tuberculosis Infection (LTBI) treatment and its associated factors among healthcare workers in a Malaysian teaching university hospital.
    PLoS One. 2024;19:e0307199.
    >> Share

  203. RODRIGUEZ-MIGUEZ Y, Lozano-Ordaz V, Ortiz-Cabrera AE, Barrios-Payan J, et al
    Effect of IL-17A on the immune response to pulmonary tuberculosis induced by high- and low-virulence strains of Mycobacterium bovis.
    PLoS One. 2024;19:e0307307.
    >> Share

  204. MAHAPATRA A, Thiruvengadam K, Nair D, Padmapriyadarsini C, et al
    Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach.
    PLoS One. 2024;19:e0305855.
    >> Share

  205. CHEKESA B, Singh H, Gonzalez-Juarbe N, Vashee S, et al
    Pangenome and genomic signatures linked to the dominance of the lineage-4 of Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia.
    PLoS One. 2024;19:e0304060.
    >> Share

  206. WILKINSON T, Garcia-Prats AJ, Sachs T, Paradkar M, et al
    Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines.
    PLoS One. 2024;19:e0305930.
    >> Share

  207. ALEXANDER FC, Mshiu JJ, Rushaigo AM, Mgina EJ, et al
    Knowledge of Tuberculosis preventive treatment among people living with HIV: A cross-sectional survey in selected regions of Tanzania.
    PLoS One. 2024;19:e0307670.
    >> Share

  208. NASIR A, Hassan II, Ma'ruf A, Suharno NE, et al
    Coping efforts made: Psychological burden of people living with tuberculosis due to social stigma in society. A qualitative phenomenology study.
    PLoS One. 2024;19:e0303331.
    >> Share

  209. CHERKOS AS, LaCourse SM, Enquobahrie DA, Escudero JN, et al
    Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.
    PLoS One. 2024;19:e0293708.
    >> Share

  210. YAN AJ, Olson AM, Weigel KM, Luabeya AK, et al
    Detection of Mycobacterium tuberculosis from tongue swabs using sonication and sequence-specific hybridization capture.
    PLoS One. 2024;19:e0308235.
    >> Share

  211. WEI G, Zhang J, Qiu X
    Application value of volumetric CT value in quantifying the activity of a pulmonary tuberculoma.
    PLoS One. 2024;19:e0306875.
    >> Share

  212. MARTINS N, Soares D, Gusmao C, Nunes M, et al
    A qualitative exploration of the impact of the COVID-19 pandemic on gender-based violence against women living with HIV or tuberculosis in Timor Leste.
    PLoS One. 2024;19:e0306106.
    >> Share

  213. ALSULAIS FM, Alhaidhal BA, Mothana RA, Alanzi AR, et al
    Identification of echinoderm metabolites as potential inhibitors targeting wild-type and mutant forms of Escherichia coli RNA polymerase (RpoB) for tuberculosis treatment.
    PLoS One. 2024;19:e0304587.
    >> Share

  214. REQUENA D, Supo-Escalante RR, Sheen P, Zimic M, et al
    Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0309352.
    >> Share

  215. KRIVOSOVA M, Dohal M, Masiarova S, Prso K, et al
    Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention.
    PLoS One. 2024;19:e0305158.
    >> Share

  216. RETA MA, Asmare Z, Sisay A, Gashaw Y, et al
    Prevalence of pulmonary tuberculosis among key and vulnerable populations in hotspot settings of Ethiopia. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0309445.
    >> Share

  217. FRITSCHI N, Gureva T, Eliseev P, Jackson C, et al
    Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study.
    PLoS One. 2024;19:e0293272.
    >> Share

  218. TOROKAA PR, Majigo MV, Kileo H, Urio L, et al
    The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.
    PLoS One. 2024;19:e0296563.
    >> Share

  219. TESEMA E, Biru M, Leta T, Kumsa A, et al
    Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends.
    PLoS One. 2024;19:e0306076.
    >> Share

  220. RAFI MA, Semanta S, Shahriar T, Hasan MJ, et al
    An approach to integrated management of diabetes in tuberculosis patients: Availability and readiness of the health facilities of Bangladesh.
    PLoS One. 2024;19:e0309372.
    >> Share

  221. VERBOVEN L, Callens S, Black J, Maartens G, et al
    A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.
    PLoS One. 2024;19:e0306101.
    >> Share

  222. SHI H, Zhu Y, Shang K, Tian T, et al
    Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches.
    PLoS One. 2024;19:e0307877.
    >> Share

  223. BLAKE E, Stringham E, Sloan-Aagard C
    Concurrent disease burden from multiple infectious diseases and the influence of social determinants in the contiguous United States.
    PLoS One. 2024;19:e0293431.
    >> Share

  224. PIRES DC, Arueira Chaves L, Dantas Cardoso CH, Faria LV, et al
    Effects of low dose computed tomography (LDCT) on lung cancer screening on incidence and mortality in regions with high tuberculosis prevalence: A systematic review.
    PLoS One. 2024;19:e0308106.
    >> Share

  225. JENNINGS K, Lembani M, Hesseling AC, Mbula N, et al
    A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.
    PLoS One. 2024;19:e0310383.
    >> Share

  226. PENG Y, Li C, Hui X, Huo X, et al
    Phenotypic and genotypic analysis of drug resistance in M. tuberculosis isolates in Gansu, China.
    PLoS One. 2024;19:e0311042.
    >> Share

  227. AZIZ ZA, Mohamad AH, Mohamad Noordin N, Mohd Shariff N, et al
    Social-behavioral insights in understanding tuberculosis transmission pattern during the COVID-19 pandemic period in Kuala Lumpur, Malaysia: The MyTBNet study protocol.
    PLoS One. 2024;19:e0307921.
    >> Share

  228. YOON JY, Kim TO, Kim JS, Kim HW, et al
    Impact of pyrazinamide usage on serious adverse events in elderly tuberculosis patients: A multicenter cohort study.
    PLoS One. 2024;19:e0309902.
    >> Share

  229. NASIR BB, Muhammed OS, Tamiru MT, Chelkeba L, et al
    Assessing the impact of COVID-19 on tuberculosis detection and treatment in healthcare facilities across Addis Ababa, Ethiopia: A comprehensive mixed-method, multi-center study.
    PLoS One. 2024;19:e0311408.
    >> Share

  230. FROMENT A, Delomez J, Da Nascimento S, Dassonville-Klimpt A, et al
    Efficacy of mefloquine and its enantiomers in a murine model of Mycobacterium avium infection.
    PLoS One. 2024;19:e0311167.
    >> Share

  231. PRAPHAKORNMANO T, Torvorapanit P, Siranart N, Ohata PJ, et al
    The effect of corticosteroids in developing active pulmonary tuberculosis among patients with COVID-19.
    PLoS One. 2024;19:e0309392.
    >> Share

  232. AHAMED FAYAZ S, Babu L, Paridayal L, Vasantha M, et al
    Machine learning algorithms to predict treatment success for patients with pulmonary tuberculosis.
    PLoS One. 2024;19:e0309151.
    >> Share

  233. ATKINSON A, Kraus D, Banholzer N, Miro JM, et al
    HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015.
    PLoS One. 2024;19:e0312035.
    >> Share

  234. SHAFIPOUR M, Mohammadzadeh A, Mahmoodi P, Dehghanpour M, et al
    Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates.
    PLoS One. 2024;19:e0309292.
    >> Share

  235. NANDU N, Miller M, Tong Y, Lu ZX, et al
    A novel dual probe-based method for mutation detection using isothermal amplification.
    PLoS One. 2024;19:e0309541.
    >> Share

  236. MAHJABEEN A, Hasan MZ, Rahman MT, Islam MA, et al
    Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets.
    PLoS One. 2024;19:e0312072.
    >> Share

  237. EVANS D, Hirasen K, Ramushu C, Long L, et al
    Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.
    PLoS One. 2024;19:e0309034.
    >> Share

  238. PELZER PT, Holleman M, Helinski MEH, Weinberg AL, et al
    The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.
    PLoS One. 2024;19:e0292981.
    >> Share

  239. ZHU Y, Shi J, Wang Q, Zhu Y, et al
    Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.
    PLoS One. 2024;19:e0309560.
    >> Share

  240. SAMBAN SS, Kunoor A, Prasanna P, Krishnakumar M, et al
    Adopting a model of antimicrobial stewardship program to anti-tubercular treatment stewardship: A single-centre experience from a private tertiary care hospital in South India.
    PLoS One. 2024;19:e0310493.
    >> Share

  241. SHEWADE HD, Ravichandran P, Pradeep SK, Kiruthika G, et al
    Bridging the "know-do" gap to improve active case finding for tuberculosis in India: A qualitative exploration into national tuberculosis elimination program staffs' perspectives.
    PLoS One. 2024;19:e0309750.
    >> Share

  242. HICKMAN JH, Swartz A, Sicwebu N, Stek C, et al
    Exploring Health-Related Quality of Life (HRQOL) among patients with HIV-associated TB in Khayelitsha, South Africa.
    PLoS One. 2024;19:e0275554.
    >> Share

  243. OFFICER K, Arango-Sabogal JC, Dufour S, Lyashchenko KP, et al
    Bayesian accuracy estimates for diagnostic tests to detect tuberculosis in captive sun bears (Helarctos malayanus) and Asiatic black bears (Ursus thibetanus) in Cambodia and Vietnam.
    PLoS One. 2024;19:e0313007.
    >> Share

  244. TURINAWE G, Asaasira D, Kajumba MB, Mugumya I, et al
    Active tuberculosis disease among people living with HIV on ART who completed tuberculosis preventive therapy at three public hospitals in Uganda.
    PLoS One. 2024;19:e0313284.
    >> Share

  245. GIRMAY G, Kiflie A, Alem M, Lemma M, et al
    Human-immunodeficiency virus infection associated with the impaired Th1 and pro-inflammatory cytokine response in latent tuberculosis-infected individuals: A comparative cross-sectional study.
    PLoS One. 2024;19:e0313306.
    >> Share

  246. KASSAW A, Kefale D, Aytenew TM, Azmeraw M, et al
    Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0312698.
    >> Share

  247. WARES DF, Mbenga M, Mirtskhulava V, Quelapio M, et al
    Introducing BPaL: Experiences from countries supported under the LIFT-TB project.
    PLoS One. 2024;19:e0310773.
    >> Share

  248. BRANDELLI COSTA A, Boeira LDS, de Almeida-Segundo DS, Chaves LW, et al
    Experiences and perspectives on rapid-test diagnosis of tuberculosis, histoplasmosis and cryptococcosis in people with advanced HIV/AIDS disease in Porto Alegre, Brazil.
    PLoS One. 2024;19:e0312204.
    >> Share

  249. IBRAHIM MAA, Mahmoud DGM, Abdelrahman AHM, Abdeljawaad KAA, et al
    Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations.
    PLoS One. 2024;19:e0314422.
    >> Share

  250. CHUMCHUEN K, Wichaidit W, Chongsuvivatwong V
    Relationship between hospitalization from cannabis usage and pulmonary tuberculosis in Thailand from 2017 to 2022.
    PLoS One. 2024;19:e0312139.
    >> Share

  251. SYED RR, Catanzaro DG, Hillery N, Crudu V, et al
    Understanding tuberculosis transmission and progression: A prospective cohort study of index cases and close contacts in Moldova.
    PLoS One. 2024;19:e0313270.
    >> Share

  252. ELDUMA AH, Holakouie-Naieni K, Almasi-Hashiani A, Foroushani AR, et al
    Correction: The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
    PLoS One. 2024;19:e0314954.
    >> Share

  253. HUDA MH, Rahman MF, Zalaya Y, Mukminin MA, et al
    A meta-analysis of technology-based interventions on treatment adherence and treatment success among TBC patients.
    PLoS One. 2024;19:e0312001.
    >> Share

  254. KEMBABAZI V, Ssentongo J, Rutebemberwa E
    Facilitators and barriers to Tuberculosis case notification among private health facilities in Kampala Capital City, Uganda.
    PLoS One. 2024;19:e0315402.
    >> Share

  255. CISSE AB, Dean AS, Van Deun A, Keysers J, et al
    Prevalence of non-tuberculous mycobacteria among people with acid-fast positive presumptive tuberculosis in Mali.
    PLoS One. 2024;19:e0301731.
    >> Share

  256. SAMUEL V, Solomons R, Mason S
    Targeted metabolomics investigation of metabolic markers of Mycobacterium tuberculosis in the cerebrospinal fluid of paediatric patients with tuberculous meningitis.
    PLoS One. 2024;19:e0314854.
    >> Share

  257. SOARES TDS, Bello GL, Dos Santos Petry IM, Nicola MRC, et al
    Laboratory validation of a simplified DNA extraction protocol followed by a portable qPCR detection of M. tuberculosis DNA suitable for point of care settings.
    PLoS One. 2024;19:e0302345.
    >> Share

  258. WARIT S, Meesawat S, Cheawchanlertfa P, Makhao N, et al
    The new gamma interferon (IFN-gamma) algorithm for tuberculosis diagnosis in cynomolgus macaques.
    PLoS One. 2024;19:e0302349.
    >> Share

  259. AYELE TK, Doungmo Goufo EF, Mugisha S
    Co-infection mathematical model for HIV/AIDS and tuberculosis with optimal control in Ethiopia.
    PLoS One. 2024;19:e0312539.
    >> Share

  260. XIONG T, Qin W, Zhang Y, Chen Y, et al
    Prognostic nutritional index and naples prognostic score as biomarkers for the prognosis of incisional wound healing after thoracolumbar tuberculosis surgery.
    PLoS One. 2024;19:e0309267.
    >> Share

  261. PARVEEN A, Bhat SA, Elnaggar M, Meade KG, et al
    Comparative analysis of WC1.1+ and WC1.2+ gammadelta T cell subset responses from cattle naturally infected with Mycobacterium bovis to repeat stimulation with mycobacterial antigens.
    PLoS One. 2024;19:e0311854.
    >> Share

  262. LIMBERIS JD, Nagel RJ, Chakravorty S, Block D, et al
    stilPCR increases the effective sequencing length of Illumina targeted next-generation sequencing.
    PLoS One. 2024;19:e0314265.
    >> Share

  263. BAKULA Z, Wuyep VB, Bartocha L, Vyazovaya A, et al
    Correction: Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria.
    PLoS One. 2024;19:e0315611.
    >> Share

  264. MALHOTRA A, Thompson R, De Vos M, David A, et al
    Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
    PLoS One. 2024;19:e0316653.
    >> Share

  265. LATHAM AS, Geer CE, Ackart DF, Weninger KN, et al
    Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain.
    PLoS One. 2024;19:e0307577.
    >> Share

  266. GUTTA S, Mannam P, Kumar V, George T, et al
    Correction: Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study.
    PLoS One. 2024;19:e0316921.
    >> Share

  267. NWOKOYE N, Ihesie A, Olabamiji J, Ochei K, et al
    Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study.
    PLoS One. 2024;19:e0316204.
    >> Share

  268. CAI N, Luo W, Ding L, Chen L, et al
    Correction: Obesity-related indicators and tuberculosis: A Mendelian randomization study.
    PLoS One. 2024;19:e0316856.
    >> Share

  269. OCHOLA EA, Mweu MM
    Performance of three diagnostic tests for tuberculosis among Human Immunodeficiency Virus (HIV) patients presenting to a health facility in an informal urban settlement in Nairobi, Kenya.
    PLoS One. 2024;19:e0307727.
    >> Share

    January 2023
  270. MONDAL R, Dusthackeer V N A, Kannan P, Singh AK, et al
    In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.
    PLoS One. 2023;18:e0282454.
    >> Share

  271. KETER AK, Lynen L, Van Heerden A, Wong E, et al
    Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a community-based tuberculosis screening study.
    PLoS One. 2023;18:e0282417.
    >> Share

  272. MATJI R, Maama L, Roscigno G, Lerotholi M, et al
    Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019.
    PLoS One. 2023;18:e0273245.
    >> Share

  273. KHOR LA, A Wahid UNI, Ling LL, Liansim SMS, et al
    Prevalence and associated factors of delayed sputum smear conversion in patients treated for smear positive pulmonary tuberculosis: A retrospective follow up study in Sabah, Malaysia.
    PLoS One. 2023;18:e0282733.
    >> Share

  274. KIM S, Hesseling AC, Wu X, Hughes MD, et al
    Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household.
    PLoS One. 2023;18:e0283290.
    >> Share

  275. CASTLE AC, Hoeppner SS, Magodoro IM, Singh U, et al
    Association between prior tuberculosis disease and dysglycemia within an HIV-endemic, rural South African population.
    PLoS One. 2023;18:e0282371.
    >> Share

  276. MBUYA AW, Mboya IB, Semvua HH, Mamuya SH, et al
    Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania.
    PLoS One. 2023;18:e0280396.
    >> Share

  277. BRAZIER E, Maruri F, Wester CW, Musick B, et al
    Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
    PLoS One. 2023;18:e0268167.
    >> Share

  278. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    >> Share

  279. GEMECHU LL, Debusho LK
    Bayesian spatial modelling of tuberculosis-HIV co-infection in Ethiopia.
    PLoS One. 2023;18:e0283334.
    >> Share

  280. MOHAMMAD RAHIMI H, Javanmard E, Taghipour A, Haghighi A, et al
    Multigene typing of Giardia Duodenalis isolated from tuberculosis and non-tuberculosis subjects.
    PLoS One. 2023;18:e0283515.
    >> Share

  281. AMARE D, Getahun FA, Mengesha EW, Dessie G, et al
    Effectiveness of healthcare workers and volunteers training on improving tuberculosis case detection: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0271825.
    >> Share

  282. WILLGERT K, da Silva S, Li R, Dandapat P, et al
    Is bovine density and ownership associated with human tuberculosis in India?
    PLoS One. 2023;18:e0283357.
    >> Share

  283. MOYO N, Tay EL, Trauer JM, Burke L, et al
    Tuberculosis notifications in regional Victoria, Australia: Implications for public health care in a low incidence setting.
    PLoS One. 2023;18:e0282884.
    >> Share

  284. MOYO S, Ismail F, Mkhondo N, van der Walt M, et al
    Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017-2019.
    PLoS One. 2023;18:e0282125.
    >> Share

  285. SINHA S, Thukral H, Shareef I, Desai D, et al
    Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
    PLoS One. 2023;18:e0272682.
    >> Share

  286. MAYITO J, Martineau AR, Tiwari D, Nakiyingi L, et al
    Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study.
    PLoS One. 2023;18:e0281559.
    >> Share

  287. SUDCHAROEN A, Ruchikajorndech G, Srisajjakul S, Pongpaibul A, et al
    Clinical characteristics and diagnosis of intestinal tuberculosis in clinical practice at Thailand's largest national tertiary referral center: An 11-year retrospective review.
    PLoS One. 2023;18:e0282392.
    >> Share

  288. MARTINEZ-OLIVARES CE, Hernandez-Pando R, Mixcoha E
    In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
    PLoS One. 2023;18:e0284264.
    >> Share

  289. PARK S, Sung C, Choi H, Lee YW, et al
    Comparison of active tuberculosis case finding strategies for immigrants in South Korea: Epidemiology and cost-effectiveness analysis.
    PLoS One. 2023;18:e0283414.
    >> Share

  290. SIMMONS JD, Segnitz RM, Dill-McFarland KA, Stein CM, et al
    Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
    PLoS One. 2023;18:e0284498.
    >> Share

  291. NGO DM, Doan NB, Tran SN, Hoang LB, et al
    Practice regarding tuberculosis care among physicians at private facilities: A cross-sectional study from Vietnam.
    PLoS One. 2023;18:e0284603.
    >> Share

  292. MOGA S, Bobosha K, Fikadu D, Zerihun B, et al
    Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    PLoS One. 2023;18:e0284737.
    >> Share

  293. SESSOLO A, Musisi E, Kaswabuli S, Zawedde J, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda.
    PLoS One. 2023;18:e0284041.
    >> Share

  294. ANDOM AT, Gilbert HN, Ndayizigiye M, Mukherjee JS, et al
    Understanding barriers to tuberculosis diagnosis and treatment completion in a low-resource setting: A mixed-methods study in the Kingdom of Lesotho.
    PLoS One. 2023;18:e0285774.
    >> Share

  295. GOROH MMD, van den Boogaard CHA, Lukman KA, Lowbridge C, et al
    Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: A qualitative study.
    PLoS One. 2023;18:e0285534.
    >> Share

  296. SILVA WCD, Camargo RNC Junior, Silva EBRD, Silva JARD, et al
    Perspectives of economic losses due to condemnation of cattle and buffalo carcasses in the northern region of Brazil.
    PLoS One. 2023;18:e0285224.
    >> Share

  297. BAENA A, Cabarcas F, Ocampo JC, Barrera LF, et al
    Large genomic deletions delineate Mycobacterium tuberculosis L4 sublineages in South American countries.
    PLoS One. 2023;18:e0285417.
    >> Share

  298. MAIN S, Triasih R, Greig J, Hidayat A, et al
    The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia.
    PLoS One. 2023;18:e0279215.
    >> Share

  299. AKALU TY, Clements ACA, Baraki AG, Alene KA, et al
    Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
    PLoS One. 2023;18:e0285404.
    >> Share

  300. KAMBLE S, Shidhaye P, Mukherjee A, Tak M, et al
    A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    PLoS One. 2023;18:e0285942.
    >> Share

  301. HASAN MZ, Ahmed S, Islam Z, Dorin F, et al
    Costs of services and funding gap of the Bangladesh National Tuberculosis Control Programme 2016-2022: An ingredient based approach.
    PLoS One. 2023;18:e0286560.
    >> Share

  302. D FREIRE I, L Fielding K, A J Moore D
    Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?
    PLoS One. 2023;18:e0286306.
    >> Share

  303. SHARANI ZZ, Ismail N, Yasin SM, Isa MR, et al
    T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.
    PLoS One. 2023;18:e0287374.
    >> Share

  304. BAATJIES L, van Rensberg IC, Snyders C, Gutschmidt A, et al
    Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.
    PLoS One. 2023;18:e0286965.
    >> Share

  305. ALEMU A, Bitew ZW, Diriba G, Seid G, et al
    Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286194.
    >> Share

  306. KAGUJJE M, Nyangu S, Maimbolwa MM, Shuma B, et al
    Strategies to increase childhood tuberculosis case detection at the primary health care level: Lessons from an active case finding study in Zambia.
    PLoS One. 2023;18:e0288643.
    >> Share

  307. FEKADU G, Wang Y, You JHS
    Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    PLoS One. 2023;18:e0288605.
    >> Share

  308. PONGMA C, Songthammanuphap S, Puthong S, Buakeaw A, et al
    Using whole blood cultures in interferon gamma release assays to detect Mycobacterium tuberculosis complex infection in Asian elephants (Elephas maximus).
    PLoS One. 2023;18:e0288161.
    >> Share

  309. GEORGE S, Syamala TS, Paranjpe A, Saalim M, et al
    Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting.
    PLoS One. 2023;18:e0289137.
    >> Share

  310. XIE M, Tsai CY, McAdams ZL, Oo M, et al
    Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice.
    PLoS One. 2023;18:e0288290.
    >> Share

  311. MEKONNEN E, Arega M, Belay DM, Birhanu D, et al
    Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of Addis Ababa, Addis Ababa, Ethiopia, a retrospective follow up study.
    PLoS One. 2023;18:e0288475.
    >> Share

  312. KURTZ SL, Ryden P, Elkins KL
    Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
    PLoS One. 2023;18:e0289358.
    >> Share

  313. KABORE OD, Millogo A, Sanogo B, Birba E, et al
    Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country.
    PLoS One. 2023;18:e0288671.
    >> Share

  314. MOLLALIGN H, Getahun M, Diriba G, Alemu A, et al
    Genetic diversity and drug sensitivity profile of Mycobacterium tuberculosis among children in Ethiopia.
    PLoS One. 2023;18:e0284363.
    >> Share

  315. LOLONG DB, Aryastami NK, Kusrini I, Tobing KL, et al
    Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia.
    PLoS One. 2023;18:e0287628.
    >> Share

  316. KATAMBA A, Ssengooba W, Sserubiri J, Semugenze D, et al
    Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
    PLoS One. 2023;18:e0284545.
    >> Share

  317. BERROCAL-ALMANZA LC, Lima M, Piotrowski H, Botticello J, et al
    Vulnerability and tuberculosis treatment outcomes in urban settings in England: A mixed-methods study.
    PLoS One. 2023;18:e0281918.
    >> Share

  318. GARG T, Nonyane BAS, Mohlamonyane M, Lebina L, et al
    Investigating linkage to care between hospitals and primary care clinics for people with TB in rural South Africa.
    PLoS One. 2023;18:e0289830.
    >> Share

  319. MASSUD A, Khan AH, Syed Sulaiman SA, Ahmad N, et al
    Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
    PLoS One. 2023;18:e0287966.
    >> Share

  320. SEJIE GA, Mahomed OH
    Potential facilitators and inhibitors to the implementation and sustainability of the community-based tuberculosis care interventions. A case study from Moshupa, Botswana.
    PLoS One. 2023;18:e0290010.
    >> Share

  321. MALECHE-OBIMBO E, Attia E, Were F, Jaoko W, et al
    Prevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya.
    PLoS One. 2023;18:e0289756.
    >> Share

  322. MALHOTRA A, Thompson R, De Vos M, David A, et al
    Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
    PLoS One. 2023;18:e0290496.
    >> Share

  323. MEESAWAT S, Aiempichitkijkarn N, Warit S, Kaewparuehaschai M, et al
    Non-invasive specimen collections for Mycobacterium tuberculosis detection in free-ranging long-tailed macaques (Macaca fascicularis).
    PLoS One. 2023;18:e0289961.
    >> Share

  324. AUNG PL, Win KM, Win Maung HM, Show KL, et al
    Determinants of correct knowledge on tuberculosis transmission and self-reported tuberculosis prevalence among general population aged 15-49 years in Myanmar.
    PLoS One. 2023;18:e0290470.
    >> Share

  325. LERTUDOMPHONWANIT T, Somboonprasert C, Lilakhunakon K, Jaovisidha S, et al
    A clinical prediction model to differentiate tuberculous spondylodiscitis from pyogenic spontaneous spondylodiscitis.
    PLoS One. 2023;18:e0290361.
    >> Share

  326. MOTTA CP, Olimpio da Silva DL, da Costa LR, Galhardo GF, et al
    Performance during the Glittre-ADL test between patients with and without post-tuberculosis bronchiectasis: A cross-sectional study.
    PLoS One. 2023;18:e0290850.
    >> Share

  327. MA Z, Fan H
    Influential factors of tuberculosis in mainland China based on MGWR model.
    PLoS One. 2023;18:e0290978.
    >> Share

  328. PEREZ-RECIO S, Grijota-Camino MD, Anibarro L, Rabunal-Rey R, et al
    Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.
    PLoS One. 2023;18:e0285917.
    >> Share

  329. RAMSAY LC, Marina Richardson, Miranda RN, Hassan M, et al
    Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
    PLoS One. 2023;18:e0290710.
    >> Share

  330. GETAHUN DA, Layland LE, Hoerauf A, Wondale B, et al
    Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years.
    PLoS One. 2023;18:e0289917.
    >> Share

  331. TOK PSK, Wong LP, Liew SM, Razali A, et al
    A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.
    PLoS One. 2023;18:e0289222.
    >> Share

  332. TORNU E, Jordan P, McCaul M
    Best practice guidelines for professional nurses to provide self-management support to adults with tuberculosis-human immunodeficiency virus coinfection: A scoping review.
    PLoS One. 2023;18:e0291529.
    >> Share

  333. SIBHAT MM, Mulugeta TN, Aklilu DW
    Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis.
    PLoS One. 2023;18:e0288132.
    >> Share

  334. KARANJA S, Aduda J, Thuo R, Wamunyokoli F, et al
    Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.
    PLoS One. 2023;18:e0290575.
    >> Share

  335. TILAHUN M, Wegayehu T, Wondale B, Gebresilase TT, et al
    Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    PLoS One. 2023;18:e0285063.
    >> Share

  336. ROMANOWSKI K, Karim ME, Gilbert M, Cook VJ, et al
    Distinct healthcare utilization profiles of high healthcare use tuberculosis survivors: A latent class analysis.
    PLoS One. 2023;18:e0291997.
    >> Share

  337. TEKESE D, Dawit D, Hawulte B, Mohammed H, et al
    Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
    PLoS One. 2023;18:e0291502.
    >> Share

  338. EREM G, Otike C, Okuja M, Ameda F, et al
    Diagnostic accuracy of chest ultrasound scan in the diagnosis of childhood tuberculosis.
    PLoS One. 2023;18:e0287621.
    >> Share

  339. OSEI E, Amu H, Kye-Duodu G, Kwabla MP, et al
    Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.
    PLoS One. 2023;18:e0291808.
    >> Share

  340. ISLAM MS, Gurley ES, Banu S, Hossain K, et al
    Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context.
    PLoS One. 2023;18:e0291484.
    >> Share

  341. WINTERS N, Schnitzer ME, Campbell JR, Ripley S, et al
    Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
    PLoS One. 2023;18:e0292106.
    >> Share

  342. ZERIHUN M, Mekonnen H, Gebretensaye TG
    Treatment outcome and associated factors among adult patients with pulmonary tuberculosis in selected health centers in Addis Ababa Ethiopia.
    PLoS One. 2023;18:e0292218.
    >> Share

  343. CHAWLA K, Burugina Nagaraja S, Siddalingaiah N, Sanju C, et al
    Tuberculosis screening for pediatric household contacts in India: Time to adapt newer strategies under the National TB Elimination Programme!
    PLoS One. 2023;18:e0292387.
    >> Share

  344. MOENS C, Filee P, Boes A, Alie C, et al
    Identification of New Mycobacterium bovis antigens and development of a multiplexed serological bead-immunoassay for the diagnosis of bovine tuberculosis in cattle.
    PLoS One. 2023;18:e0292590.
    >> Share

  345. VERBOVEN L, Phelan J, Heupink TH, Van Rie A, et al
    Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
    PLoS One. 2023;18:e0293254.
    >> Share

  346. MEJIA-PONCE PM, Ramos-Gonzalez EJ, Ramos-Garcia AA, Lara-Ramirez EE, et al
    Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico.
    PLoS One. 2023;18:e0292965.
    >> Share

  347. MUSHTAQ F, Raza SM, Ahmad A, Aslam H, et al
    Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
    PLoS One. 2023;18:e0293194.
    >> Share

  348. HAVUMAKI J, Warren JL, Zelner J, Menzies NA, et al
    Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis.
    PLoS One. 2023;18:e0293519.
    >> Share

  349. MANDO TC, Sandy C, Chadambuka A, Gombe NT, et al
    Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
    PLoS One. 2023;18:e0293867.
    >> Share

  350. VERMA-KUMAR S, Abraham D, Dendukuri N, Cheeran JV, et al
    Correction: Serodiagnosis of Tuberculosis in Asian Elephants (Elephas maximus) in Southern India: A Latent Class Analysis.
    PLoS One. 2023;18:e0294550.
    >> Share

  351. GRAY AT, Macpherson L, Carlin F, Sossen B, et al
    Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293535.
    >> Share

  352. SHIN HJ, Yoon JY, Na YO, Lee JK, et al
    Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.
    PLoS One. 2023;18:e0294490.
    >> Share

  353. YANG Y, Liu L, Yang X, Li L, et al
    Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016-2020.
    PLoS One. 2023;18:e0280578.
    >> Share

  354. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    >> Share

  355. TRIVEDI P, Chaturvedi V
    Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
    PLoS One. 2023;18:e0292397.
    >> Share

  356. AFFUL P, Vechey GA, Leta PK, Gbafu FB, et al
    Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
    PLoS One. 2023;18:e0294928.
    >> Share

  357. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis.
    PLoS One. 2023;18:e0289336.
    >> Share

  358. SPRUIJT I, Alam Y, Nguyen H, Myrzaliev B, et al
    Digital health solutions and integrated COVID-19 and TB services to help recover TB care and prevention services in the COVID-19 pandemic: A descriptive study in four high TB burden countries.
    PLoS One. 2023;18:e0293964.
    >> Share

  359. MOREY-LEON G, Mejia-Ponce PM, Granda Pardo JC, Munoz-Mawyin K, et al
    A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    PLoS One. 2023;18:e0294670.
    >> Share

  360. BONGOMIN F, Olum R, Kibone W, Namusobya M, et al
    Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: A protocol for a living systematic review and meta-analysis.
    PLoS One. 2023;18:e0294634.
    >> Share

  361. KWAK SH, Jeong D, Mok J, Jeon D, et al
    Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0295556.
    >> Share

  362. NOIA MACIEL EL, Negri LDSA, Guidoni LM, Fregona GC, et al
    The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    PLoS One. 2023;18:e0287961.
    >> Share

  363. TIRUNEH MG, Fenta ET, Anagaw TF, Bogale EK, et al
    Tuberculosis infection control practice and associated factors among health care workers in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0295555.
    >> Share

  364. SCIAUDONE M, Carpena R, Calderon M, Sheen P, et al
    Rapid detection of Mycobacterium tuberculosis using recombinase polymerase amplification: A pilot study.
    PLoS One. 2023;18:e0295610.
    >> Share

  365. ODONGO D, Omech B, Acanga A
    Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    PLoS One. 2023;18:e0288761.
    >> Share

  366. GIRIDHARAN P, Selvaraju S, Rao R, Rade K, et al
    Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
    PLoS One. 2023;18:e0294254.
    >> Share

  367. JAMIL B, Nair D, Thekkur P, Laeeq N, et al
    Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in Pakistan.
    PLoS One. 2023;18:e0295580.
    >> Share

  368. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    >> Share

  369. ATRE S, Jagtap J, Faqih M, Dumbare Y, et al
    Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
    PLoS One. 2023;18:e0295508.
    >> Share

  370. GILS T, Kamele M, Madonsela T, Bosman S, et al
    Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    PLoS One. 2023;18:e0296197.
    >> Share

    January 2021
  371. LANSANG MAD, Alejandria MM, Law I, Juban NR, et al
    High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey.
    PLoS One. 2021;16:e0252240.
    >> Share

  372. TAMUHLA T, Dave JA, Raubenheimer P, Tiffin N, et al
    Diabetes in a TB and HIV-endemic South African population: Analysis of a virtual cohort using routine health data.
    PLoS One. 2021;16:e0251303.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016